🌀 New tool Cochlea Simulator: explore the cochlea in 3D, from the travelling wave to implant stimulation. →🎧 New tool REM & RECD Workshop: measure what the device actually delivers in the ear. →🔧 New tool Device Technology Workshop: from WDRC to frequency lowering, what happens inside a hearing aid? →🎚 Simulator Audiometry Simulator: pure tones, masking and speech tests on a virtual patient. →🧩 Tool Device Selection Workshop: which device type and coupling suits which loss? →🩺 Guide Hearing & Balance Health Guide: from tinnitus to vertigo, A to Z. →🧠 Expert view In-depth pieces for clinicians, academics and graduate students. →📚 Glossary English–Turkish audiology terms, card by card. →📊 ODAK 82 assessment tools and scales in one place. →🎓 Audiology 101 Lecture notes, quizzes and case practice. →📝 New article AI tool CochleaNet assesses every neuron in the gene-treated cochlea one by one →🏛️ Congress notes BAA 2026 Liverpool: notes from the clinical audiology agenda →
Home / Hearing & Balance Health Guide / Non-Syndromic (Genetic) Hearing Loss
◗ Inner ear (cochlea)

Non-Syndromic (Genetic) Hearing Loss

Non-syndromic hearing loss is hearing loss, mostly inherited, that affects hearing alone without involving any other organ. It accounts for a large share of congenital hearing loss, and with early diagnosis and appropriate rehabilitation, language development can be largely protected.

⏱🔄 Last reviewed: October 2026◈ Evidence-based review

At a glance

What is it?

A genetic hearing loss that affects hearing alone, with no findings in other body systems; the commonest cause is variants in the GJB2 (Connexin 26) gene.

Main symptoms

The baby does not respond to sound or turn to their name, and language development is delayed; the loss is usually bilateral and sensorineural.

Urgency

It is not an emergency, but early diagnosis is decisive for language development (the 1-3-6 principle).

Main approach

Early hearing aid fitting and intensive auditory-verbal rehabilitation are the core of management, with a cochlear implant in suitable cases.

~70%Non-syndromic share of prelingual genetic loss
1-3/1000Permanent hearing loss in newborns
GJB2Commonest single genetic cause
1-3-6Screen by 1, diagnose by 3, intervene by 6 months

Medical disclaimer. This content is for informational purposes only and does not replace a physician’s examination, diagnosis or treatment; it should not be used as medical advice. For your complaints or personal situation, always consult an ear, nose and throat physician and an audiologist.

!When to see a doctor / audiologist?

If your baby did not pass the newborn hearing screen, does not respond to sound, does not turn to their name or has delayed speech and language development, see an audiologist without delay. No hearing loss in the family does not rule out a genetic cause, and assessment matters even more if the parents are related.

Definition and epidemiology

Hereditary hearing loss is called “non-syndromic” when no other finding, such as eye, kidney or heart involvement, is present, and “syndromic” when it occurs with findings in other systems. About 70% of prelingual genetic hearing loss is non-syndromic (Shearer et al., 2026).

Permanent hearing loss affects about 1-3 in every 1000 newborns, and a large proportion of it is genetic (Korver et al., 2017; Morton and Nance, 2006). About 80% of non-syndromic loss is autosomal recessive and 19% autosomal dominant, while X-linked and mitochondrial forms together account for less than 1%. Recessive forms are usually congenital and more severe (Shearer et al., 2026).

The commonest single genetic cause is variants in the GJB2 gene (Connexin 26 protein), which helps maintain potassium balance in the inner ear (Kenneson et al., 2002).

Affected region: Inner ear (cochlea). The most common forms, such as GJB2, are cochlear in origin; the loss is usually bilateral and sensorineural. No health problem other than hearing is expected (non-syndromic).

Symptoms and signs

In congenital forms the baby does not respond to sound, does not turn to their name and shows delayed speech and language development. Thanks to screening programmes, most cases are now identified in the newborn period before any symptoms appear.

Some genetic forms are mild at birth and progress over time, so hearing may decline as the child grows. Autosomal dominant forms usually begin after language has developed and are progressive. The loss is usually bilateral and sensorineural.

In non-syndromic loss no health problem other than hearing is expected, which helps to distinguish it from syndromic forms.

Causes and risk factors

More than 150 genes have been linked to non-syndromic hearing loss (Shearer et al., 2026). The loci are named DFNB for recessive, DFNA for dominant and DFNX for X-linked forms. GJB2 is the commonest cause.

Consanguineous marriage increases the frequency of autosomal recessive forms, so a history of parental relatedness and of hearing loss in the family are important risk indicators.

Genetic counselling gives families information on the mode of inheritance, the recurrence risk and the diagnostic options (Shearer et al., 2026).

Audiological and clinical assessment

The pathway begins with newborn hearing screening; babies who do not pass are referred for full audiological assessment. The aim is to confirm hearing loss as early as possible.

  • Newborn screening: OAE, automated ABR or both.
  • Diagnostic ABR and ASSR: establish frequency-specific hearing thresholds in infants.
  • Behavioural audiometry: used as the child grows to confirm thresholds.
  • Genetic testing: targeted tests or gene panels, starting with GJB2, confirm the diagnosis and help predict the prognosis.
  • Congenital CMV testing: recommended in the first weeks after birth to exclude the commonest non-genetic cause (JCIH, 2019).

To exclude syndromic causes, an eye examination (Usher syndrome), an ECG where indicated (Jervell and Lange-Nielsen syndrome) and temporal bone imaging (enlarged vestibular aqueduct) may be arranged.

Frequency (Hz) 0 20 40 60 80 100 120 125 250 500 1k 2k 4k 6k 8k Normal limit (25 dB) < < Hearing level (dB HL)
Right ear (illustrative)○ Air conduction< Bone conduction Normal limit (25 dB)
A common picture in congenital non-syndromic loss: a bilateral, relatively flat, severe sensorineural loss (no air-bone gap; at the high frequencies bone conduction cannot be measured because of the audiometer’s output limit). The degree can range from mild to profound. The chart is illustrative.

Treatment and audiological rehabilitation

The core approach is early hearing aid fitting and intensive auditory-verbal rehabilitation. The international target is screening by 1 month, diagnosis by 3 months and intervention by 6 months (the 1-3-6 principle); programmes that already meet it are encouraged to aim for 1-2-3 months (JCIH, 2019).

For mild to severe losses, appropriately fitted hearing aids are the first choice. When hearing aids give too little benefit in severe or profound loss, a cochlear implant is considered; in cochlear forms such as GJB2-related loss, implant outcomes are usually very good.

Success depends largely on an early start and family involvement, and auditory-verbal therapy and language support continue throughout.

Impact on quality of life and advice

With early diagnosis and rehabilitation, a child’s language, academic and social development can keep close to that of their peers. Late diagnosis, by contrast, can leave lasting language delays.

Families are advised to have genetic counselling, to set realistic expectations and to keep up regular follow-up. Because the loss can progress, hearing and device settings should be reassessed at regular intervals.

❝ Cite this page

If you used this review, you can cite it as follows (APA 7):

Auditory Scene. (2026). Non-Syndromic (Genetic) Hearing Loss. Hearing & Balance Health Guide. https://auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/non-sendromik-isitme-kayiplari/

Permanent link: auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/non-sendromik-isitme-kayiplari/ · Last reviewed: October 2026 · License: CC BY-NC-ND 4.0

References

  1. Joint Committee on Infant Hearing. (2019). Year 2019 position statement: Principles and guidelines for early hearing detection and intervention programs. Journal of Early Hearing Detection and Intervention, 4(2), 1-44.
  2. Kenneson, A., Van Naarden Braun, K., & Boyle, C. (2002). GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: A HuGE review. Genetics in Medicine, 4(4), 258-274.
  3. Korver, A. M. H., Smith, R. J. H., Van Camp, G., et al. (2017). Congenital hearing loss. Nature Reviews Disease Primers, 3, 16094.
  4. Morton, C. C., & Nance, W. E. (2006). Newborn hearing screening: A silent revolution. New England Journal of Medicine, 354(20), 2151-2164.
  5. Shearer, A. E., Hildebrand, M. S., Odell, A. M., et al. (2026). Hereditary hearing loss and deafness overview (originally published 1999). GeneReviews. University of Washington.

Frequently asked questions

We have no hearing loss in the family; why could my child’s be genetic?

Most non-syndromic hearing loss is inherited in an autosomal recessive pattern. Both parents can have normal hearing and still each carry the same gene change, and the child can then have hearing loss. So the absence of hearing loss in the family does not rule out a genetic cause.

Why is genetic testing important?

Genetic testing confirms the cause of the hearing loss and can also indicate whether it is likely to progress and how much a cochlear implant may help. It also allows the family to receive counselling about the recurrence risk.

Will my child’s hearing get worse in the future?

Some genetic forms stay stable while others progress over time. That is why regular hearing checks and up-to-date device settings are important.

Does a cochlear implant work in genetic hearing loss?

Yes. In genetic forms that affect the cochlea in particular, a cochlear implant usually gives very good results in children who gain too little from hearing aids. The earlier it is provided, the greater its contribution to language development.

Does early diagnosis really make a difference?

Yes. The earlier hearing loss is identified and rehabilitation begins, the better the child’s language and speech development. This is why newborn hearing screening matters so much.

⇄ Compare conditions

Pick conditions from the menus and see their features side by side. You can compare up to 4 columns.

Try it in the simulator

OAE SimulatorRun a newborn OAE screen on a virtual infant.Open the simulator →
ABR SimulatorEstimate hearing thresholds with ABR in an infant.Open the simulator →